Aadi Bioscience, Inc. (AADI) Tops Q3 EPS by 9c

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q3 EPS of ($0.68), $0.09 better than the analyst estimate of ($0.77). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $3.11 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• JPMorgan Downgrades HCL Technologies (HCLT:IN) to Underweight
• Alimentation Couche-Tard Inc (ATD/B:CN) (ANCUF) PT Raised to Cdn$104 at UBS